Advanced radiotherapy for prostate cancer to cut sessions from 20 to five
Reported byBBC Health ↗·Sourced by Goodlede
NHS now offering stereotactic body radiotherapy (SBRT) to eligible prostate cancer patients, reducing treatment from 20 sessions to 5, based on clinical evidence supporting efficacy and reduced side effects
Does not prove universal effectiveness for all prostate cancer types/stages; eligibility criteria apply; long-term outcome data may still be emerging; availability depends on NHS implementation across regions
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at BBC Health
Read original story ↗↻ Refreshed daily
More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Science & Health
Metabolite profiling of saliva for the discrimination of Behcet's disease, Sjögren's syndrome, and recurrent aphthous stomatitis
PLOS ONE · Caution
Environment
UK's last outstanding coal mine plan rejected
BBC Science & Environment · Verified
Animals
Water voles return to reserve after 40 years
BBC Science & Environment · Caution